Burney CO Bristol Myers Squibb CO Transaction History

Burney CO

$2.54 Billion
Q3 2024

A detailed history of Burney CO transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Burney CO holds 12,237 shares of BMY stock, worth $706,809. This represents 0.02% of its overall portfolio holdings.

Number of Shares

12,237

Previous 13,771 11.14%

Holding current value

$706,809

Previous $571,000 10.86%

% of portfolio

0.02%

Previous 0.02%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 18, 2024	SELL	$39.66 - $51.75 $60,838 - $79,384	-1,534 Reduced 11.14%	12,237 $633,000
Q2 2024 Jul 29, 2024	SELL	$40.25 - $52.99 $13,886 - $18,281	-345 Reduced 2.44%	13,771 $571,000
Q1 2024 May 22, 2024	SELL	$47.98 - $54.4 $16,649 - $18,876	-347 Reduced 2.4%	14,116 $765,000
Q4 2023 Feb 12, 2024	SELL	$48.48 - $57.85 $518,881 - $619,168	-10,703 Reduced 42.53%	14,463 $742,000
Q3 2023 Nov 08, 2023	SELL	$57.89 - $64.73 $1.98 Million - $2.21 Million	-34,140 Reduced 57.57%	25,166 $1.46 Million
Q2 2023 Aug 09, 2023	BUY	$63.71 - $70.74 $2.99 Million - $3.31 Million	46,858 Added 376.43%	59,306 $3.79 Million
Q1 2023 May 10, 2023	BUY	$65.71 - $74.53 $1,314 - $1,490	20 Added 0.16%	12,448 $862,000
Q4 2022 Feb 06, 2023	SELL	$68.48 - $81.09 $15,750 - $18,650	-230 Reduced 1.82%	12,428 $894,000
Q3 2022 Nov 15, 2022	SELL	$0.13 - $76.84 $8 - $5,148	-67 Reduced 0.53%	12,658 $900,000
Q2 2022 Aug 12, 2022	SELL	$72.62 - $79.98 $29,048 - $31,992	-400 Reduced 3.05%	12,725 $980,000
Q1 2022 May 09, 2022	SELL	$61.48 - $73.72 $13,587 - $16,292	-221 Reduced 1.66%	13,125 $959,000
Q4 2021 Feb 11, 2022	SELL	$53.63 - $62.52 $29,442 - $34,323	-549 Reduced 3.95%	13,346 $832,000
Q3 2021 Nov 12, 2021	BUY	$59.17 - $69.31 $10,887 - $12,753	184 Added 1.34%	13,895 $822,000
Q2 2021 Aug 06, 2021	SELL	$61.91 - $67.42 $9,534 - $10,382	-154 Reduced 1.11%	13,711 $916,000
Q1 2021 May 13, 2021	BUY	$59.34 - $66.74 $51,981 - $58,464	876 Added 6.74%	13,865 $875,000
Q4 2020 Feb 11, 2021	SELL	$57.74 - $65.43 $101,853 - $115,418	-1,764 Reduced 11.96%	12,989 $806,000
Q3 2020 Dec 14, 2020	SELL	$57.43 - $63.64 $646,661 - $716,586	-11,260 Reduced 43.29%	14,753 $890,000
Q2 2020 Aug 13, 2020	SELL	$54.82 - $64.09 $662,938 - $775,040	-12,093 Reduced 31.74%	26,013 $1.53 Million
Q1 2020 May 13, 2020	SELL	$46.4 - $67.43 $3.08 Million - $4.48 Million	-66,469 Reduced 63.56%	38,106 $2.12 Million
Q4 2019 Feb 14, 2020	BUY	$49.21 - $64.19 $4.75 Million - $6.19 Million	96,446 Added 1186.44%	104,575 $6.71 Million
Q3 2019 Nov 12, 2019	SELL	$42.77 - $50.71 $21,213 - $25,152	-496 Reduced 5.75%	8,129 $412,000
Q2 2019 Aug 12, 2019	SELL	$44.62 - $49.34 $44,620 - $49,340	-1,000 Reduced 10.39%	8,625 $391,000
Q1 2019 May 13, 2019	SELL	$45.12 - $53.8 $17,145 - $20,444	-380 Reduced 3.8%	9,625 $459,000
Q4 2018 Feb 12, 2019	BUY	$48.76 - $63.23 $43,591 - $56,527	894 Added 9.81%	10,005 $520,000
Q3 2018 Nov 13, 2018	SELL	$55.19 - $62.25 $233,343 - $263,193	-4,228 Reduced 31.7%	9,111 $566,000
Q2 2018 Aug 13, 2018	SELL	$50.53 - $62.98 $10,813 - $13,477	-214 Reduced 1.58%	13,339 $738,000
Q1 2018 May 08, 2018	SELL	$59.92 - $68.98 $62,856 - $72,360	-1,049 Reduced 7.18%	13,553 $857,000
Q4 2017 Feb 13, 2018	BUY	$59.94 - $65.35 $68,931 - $75,152	1,150 Added 8.55%	14,602 $895,000
Q3 2017 Nov 13, 2017	SELL	$55.23 - $63.74 $453,548 - $523,432	-8,212 Reduced 37.91%	13,452 $848,000
Q3 2017 Nov 09, 2017	BUY	$55.23 - $63.74 $1.2 Million - $1.38 Million	21,664	21,664 $1.21 Million

Others Institutions Holding BMY

# of Institutions

2,536

Shares Held

1.47B

Call Options Held

31.6M

Put Options Held

35M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $123B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Burney CO, based on Form 13F filings with the SEC.

News

Stay updated on Burney CO with notifications on news.

Account